E-LIB Suche - Ergebnisse für: Shalley N. Kudalkar

1

Exploring APOBEC3A and APOBEC3B substrate specificity and t..:

Papini, Christina ; Wang, Zechen ; Kudalkar, Shalley N....
iScience. 25 (2022) 10 - p. 105077 , 2022

Link: https://doi.org/10.1016/..

2

Exploring APOBEC3A and APOBEC3B substrate specificity and t..:

Papini, Christina ; Wang, Zechen ; Kudalkar, Shalley N....
iScience. 25 (2022) 10 - p. 105271 , 2022

Link: https://doi.org/10.1016/..

3

Potent Noncovalent Inhibitors of the Main Protease of SARS-..:

Zhang, Chun-Hui ; Stone, Elizabeth A. ; Deshmukh, Maya...
ACS Central Science. 7 (2021) 3 - p. 467-475 , 2021

Link: https://doi.org/10.1021/..

4

Long‐acting and extended‐release implant and nanoformulatio..:

Beloor, Jagadish ; Kudalkar, Shalley N. ; Buzzelli, Gina...
Bioengineering & Translational Medicine. 7 (2021) 1 - p. , 2021

Link: https://doi.org/10.1002/..

5

Structure-Guided Identification of DNMT3B Inhibitors:

Newton, Ana S. ; Faver, John C. ; Micevic, Goran...
ACS Medicinal Chemistry Letters. 11 (2020) 5 - p. 971-976 , 2020

Link: https://doi.org/10.1021/..

6

Structural and pharmacological evaluation of a novel non-nu..:

Kudalkar, Shalley N. ; Ullah, Irfan ; Bertoletti, Nicole...
Antiviral Research. 167 (2019) - p. 110-116 , 2019

Link: https://doi.org/10.1016/..

7

Molecular and cellular studies evaluating a potent 2-cyanoi..:

Sasaki, Tomoaki ; Gannam, Zira T.K. ; Kudalkar, Shalley N....
Bioorganic & Medicinal Chemistry Letters. 29 (2019) 16 - p. 2182-2188 , 2019

Link: https://doi.org/10.1016/..

8

Reply to Pandey et al.: Understanding the efficacy of a pot..:

Kudalkar, Shalley N. ; Beloor, Jagadish ; Quijano, Elias...
Proceedings of the National Academy of Sciences. 115 (2018) 35 - p. , 2018

Link: https://doi.org/10.1073/..

9

From in silico hit to long-acting late-stage preclinical ca..:

Kudalkar, Shalley N. ; Beloor, Jagadish ; Quijano, Elias...
Proceedings of the National Academy of Sciences of the United States of America. 115 (2018) 4 - p. E802-E811 , 2018

Link: https://www.jstor.org/st..

10

REPLY TO PANDEY ET AL.: Understanding the efficacy of a pot..:

Kudalkar, Shalley N. ; Beloor, Jagadish ; Quijano, Elias...
Proceedings of the National Academy of Sciences of the United States of America. 115 (2018) 35 - p. E8114-E8115 , 2018

Link: https://www.jstor.org/st..

11

DRONE: Direct Tracking of DNA Cytidine Deamination and Othe..:

Sasaki, Tomoaki ; Kudalkar, Shalley N. ; Bertoletti, Nicole.
Analytical Chemistry. 90 (2018) 20 - p. 11735-11740 , 2018

Link: https://doi.org/10.1021/..

12

Covalent inhibitors for eradication of drug-resistant HIV-1..:

Chan, Albert H. ; Lee, Won-Gil ; Spasov, Krasimir A....
Proceedings of the National Academy of Sciences. 114 (2017) 36 - p. 9725-9730 , 2017

Link: https://doi.org/10.1073/..

13

Covalent inhibitors for eradication of drug-resistant HIV-1..:

Chan, Albert H. ; Lee, Won-Gil ; Spasov, Krasimir A....
Proceedings of the National Academy of Sciences of the United States of America. 114 (2017) 36 - p. 9725-9730 , 2017

Link: https://www.jstor.org/st..

14

From in silico hit to long-acting late-stage preclinical ca..:

Kudalkar, Shalley N. ; Beloor, Jagadish ; Quijano, Elias...
Proceedings of the National Academy of Sciences. 115 (2017) 4 - p. , 2017

Link: https://doi.org/10.1073/..

15

The Structural Basis of Cyclooxygenase‐2 Inhibition by Fena..:

Xu, Shu ; Banerjee, Surajit ; Kudalkar, Shalley N...
The FASEB Journal. 30 (2016) S1 - p. , 2016

Link: https://doi.org/10.1096/..